CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
|
4 Months Ended |
12 Months Ended |
Dec. 31, 2020 |
Dec. 31, 2021 |
| Cash Flows from Operating Activities: |
|
|
| Net income (loss) |
$ (12,971,424)
|
$ 3,202,748
|
| Adjustments to reconcile net income (loss) to net cash used in operating activities: |
|
|
| Change in fair value of derivative warrant liabilities |
12,110,000
|
(4,511,000)
|
| Offering costs allocated to derivative warrant liabilities |
749,253
|
|
| Payment of formation costs through issuance of Class B ordinary shares |
5,000
|
|
| Income from investments held in Trust Account |
(1,973)
|
(18,965)
|
| Changes in operating assets and liabilities: |
|
|
| Prepaid expenses |
(237,088)
|
135,895
|
| Accounts payable |
|
305,022
|
| Accrued expenses |
|
(9,934)
|
| Net cash used in operating activities |
(346,232)
|
(896,234)
|
| Cash Flows from Investing Activities |
|
|
| Cash deposited in Trust Account |
(232,300,000)
|
|
| Net cash used in investing activities |
(232,300,000)
|
|
| Cash Flows from Financing Activities: |
|
|
| Proceeds from sale of Units, net of underwriting discounts paid and reimbursements |
226,150,000
|
|
| Proceeds from sale of Private Placement Warrants |
8,900,000
|
|
| Repayment of promissory note - related party |
(124,826)
|
|
| Payment of offering costs |
(372,594)
|
(25,000)
|
| Net cash provided by (used in) financing activities |
234,552,580
|
(25,000)
|
| Net change in cash |
1,906,348
|
(921,234)
|
| Cash - beginning of the period |
0
|
1,906,348
|
| Cash - ending of the period |
1,906,348
|
$ 985,114
|
| Supplemental disclosure of noncash financing activities: |
|
|
| Warrant liabilities in connection with initial public offering |
22,529,000
|
|
| Deferred underwriting fee payable |
8,050,000
|
|
| Accrued offering costs |
49,934
|
|
| Offering costs paid by Sponsor in exchange for Founder Shares |
20,000
|
|
| Offering costs paid directly through note payable |
$ 124,826
|
|